COM:HELIUSMEDICAL
Helius Medical Technologies
- Stock
Last Close
0.47
21/11 21:00
Market Cap
2.54M
Beta: -
Volume Today
57.45K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 196K - | 495K 152.55% | 493.50K 0.30% | 432.50K 12.36% | 532.50K 23.12% | 523K 1.78% | |||||
average payables | 1.08M - | 2.82M 160.99% | 2.94M 4.10% | 2.03M 30.71% | 1.21M 40.44% | 908K 25.05% | 848K 6.61% | 579K 31.72% | |||
average receivables | 4.42K - | 116.92K 2,547.27% | 464.50K 297.29% | 489.50K 5.38% | 424.50K 13.28% | 402K 5.30% | 240.50K 40.17% | 297K 23.49% | 490K 64.98% | ||
book value per share | 0.00 - | -4.79 19,209,212.60% | -7.23 50.81% | -14.07 94.58% | 15.14 207.58% | 7.75 48.80% | 3.23 58.30% | 4.58 41.77% | 0.60 86.82% | 3.87 540.14% | |
capex per share | -0.36 - | -0.68 89.37% | -0.47 30.63% | -0.06 87.53% | -0.02 61.00% | -0.00 94.47% | -0.05 3,687.62% | ||||
capex to depreciation | -11.18 - | -7.46 33.27% | -1.85 75.22% | -0.15 92.14% | -0.18 23.59% | -0.07 62.86% | -0.18 168.52% | ||||
capex to operating cash flow | 0.01 - | 0.02 128.09% | 0.02 25.04% | 0.01 64.52% | 0.00 29.86% | 0.00 71.60% | 0.00 134.36% | ||||
capex to revenue | -0.92 - | -0.24 74.37% | -0.11 55.12% | -0.11 1.30% | -0.02 79.86% | -0.05 108.47% | |||||
cash per share | 0.00 - | 2.44 9,794,255.09% | 5.60 129.22% | 10.45 86.45% | 39.30 276.12% | 7.25 81.55% | 2.78 61.64% | 4.48 61.07% | 1.08 75.94% | 8.52 690.83% | |
days of inventory on hand | 258.00 - | 365.94 41.84% | 583.02 59.32% | 464.33 20.36% | 223.90 51.78% | ||||||
days payables outstanding | 723.10 - | 702.72 2.82% | 1.31K 86.33% | 494.29 62.25% | 260.15 47.37% | ||||||
days sales outstanding | 209.99 - | 140.05 33.31% | 127.00 9.31% | 175.51 38.19% | 159.08 9.36% | 361.03 126.95% | |||||
debt to assets | 0.15 - | 0.06 - | 0.01 77.42% | 0.00 98.47% | 0.01 2,891.11% | 0.01 16.46% | |||||
debt to equity | -0.13 - | 0.11 - | 0.02 78.47% | 0.00 98.87% | 0.01 4,963.43% | 0.02 79.73% | |||||
dividend yield | |||||||||||
earnings yield | -0.00 - | -0.00 695.95% | -0.00 68.34% | -0.00 16.47% | -0.00 12.33% | 0.00 223.78% | -0.02 619.50% | -0.03 61.17% | -0.06 113.24% | -1.81 2,887.39% | |
enterprise value | 6.82B - | 7.14B 4.70% | 5.74B 19.62% | 11.47B 99.85% | 10.41B 9.25% | 1.27B 87.77% | 786.99M 38.19% | 626.53M 20.39% | 192.74M 69.24% | -237.56K 100.12% | |
enterprise value over ebitda | -6.39K - | -807.49 87.37% | -667.72 17.31% | -649.42 2.74% | -423.10 34.85% | -33.57 92.06% | -55.83 66.28% | -34.90 37.48% | -11.98 65.68% | 0.02 100.16% | |
ev to operating cash flow | -19.56K - | -1.13K 94.22% | -728.02 35.56% | -593.64 18.46% | -530.57 10.62% | -60.63 88.57% | -67.05 10.57% | -46.80 30.20% | -13.47 71.22% | 0.02 100.17% | |
ev to sales | 21.78K - | 851.11 96.09% | 1.19K 39.89% | 1.20K 0.81% | 244.91 79.60% | -0.37 100.15% | |||||
free cash flow per share | -0.97 - | -19.39 1,905.28% | -16.55 14.63% | -36.66 121.44% | -30.81 15.94% | -28.36 7.97% | -9.86 65.24% | -5.47 44.49% | -1.06 80.60% | -17.18 1,518.72% | |
free cash flow yield | -0.00 - | -0.00 1,631.39% | -0.00 55.13% | -0.00 23.84% | -0.00 13.06% | -0.02 769.08% | -0.01 10.56% | -0.02 41.12% | -0.07 227.93% | -2.14 2,990.46% | |
graham net net | 0.00 - | -6.06 24,283,163.90% | -8.52 40.51% | -15.42 81.07% | 12.31 179.81% | 2.23 81.91% | 0.85 61.68% | 3.49 309.55% | 0.44 87.35% | 0.90 103.34% | |
graham number | 0.04 - | 54.25 132,971.46% | 64.13 18.20% | 129.09 101.30% | 122.37 5.21% | 31.70 74.09% | 29.09 8.24% | 27.58 5.20% | 3.56 87.11% | 35.59 900.82% | |
income quality | 0.33 - | 0.71 117.53% | 0.65 7.85% | 0.69 5.30% | 0.69 0.59% | 2.15 213.19% | 0.83 61.31% | 0.74 11.12% | 1.02 37.73% | 1.18 15.74% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.18 Infinity% | 0.20 11.43% | 0.08 60.43% | 0.01 89.58% | 0.00 61.47% | |
interest coverage | -50.23 - | -6.23 87.60% | -4.42 29.03% | -13.69 209.85% | -17.70 - | -47.74 169.76% | |||||
interest debt per share | 0.54 - | 3.50 546.06% | 11.61 231.89% | 2.99 74.22% | 0.85 71.73% | 0.08 91.02% | 0.00 98.39% | 0.07 5,627.63% | 0.52 638.54% | ||
inventory turnover | 1.41 - | 1.00 29.50% | 0.63 37.23% | 0.79 25.56% | 1.63 107.38% | ||||||
invested capital | -0.13 - | 0.11 - | 0.02 78.47% | 0.00 98.87% | 0.01 4,963.43% | 0.02 79.73% | |||||
market cap | 6.82B - | 7.14B 4.70% | 5.74B 19.59% | 11.48B 99.85% | 10.44B 9.08% | 1.28B 87.75% | 790.23M 38.17% | 637.53M 19.32% | 207.18M 67.50% | 4.89M 97.64% | |
net current asset value | 9 - | -1.56M 17,365,666.67% | -3.44M 120.36% | -7.68M 123.03% | 8.99M 217.02% | 2.73M 69.64% | 2.01M 26.38% | 9.75M 385.22% | 7.56M 22.44% | 1.96M 74.13% | |
net debt to ebitda | 0.00 - | 0.05 561,545.14% | 0.31 555.51% | 0.31 1.42% | 1.04 230.23% | 0.13 87.77% | 0.23 80.77% | 0.61 166.65% | 0.90 46.41% | 0.42 52.82% | |
net income per share | -2.96 - | -27.29 821.85% | -25.28 7.36% | -52.64 108.25% | -43.97 16.48% | 5.76 113.11% | -11.64 301.91% | -7.38 36.61% | -0.93 87.39% | -14.56 1,464.73% | |
operating cash flow per share | -0.97 - | -19.39 1,905.28% | -16.55 14.63% | -36.30 119.28% | -30.14 16.98% | -27.89 7.46% | -9.80 64.86% | -5.45 44.39% | -1.06 80.54% | -17.13 1,516.14% | |
payables turnover | 0.50 - | 0.52 2.90% | 0.28 46.33% | 0.74 164.90% | 1.40 90.00% | ||||||
receivables turnover | 1.74 - | 2.61 49.94% | 2.87 10.27% | 2.08 27.64% | 2.29 10.33% | 1.01 55.94% | |||||
research and ddevelopement to revenue | 20.79 - | 5.39 74.09% | 6.93 28.65% | 11.48 65.54% | 5.42 52.81% | 4.57 15.64% | |||||
return on tangible assets | -118.59K - | -7.31 99.99% | -3.49 52.28% | -4.12 17.93% | -1.03 75.01% | 0.51 149.49% | -2.65 620.36% | -1.39 47.40% | -0.73 47.44% | -1.15 57.59% | |
revenue per share | 0.73 - | 1.99 170.61% | 0.55 72.23% | 0.21 61.50% | 0.06 72.56% | 1.06 1,716.89% | |||||
roe | -118.59K - | 5.69 100.00% | 3.50 38.57% | 3.74 7.02% | -2.90 177.63% | 0.74 125.60% | -3.60 584.17% | -1.61 55.28% | -1.54 4.31% | -3.77 144.44% | |
roic | -118.59K - | 5.58 100.00% | 3.43 38.53% | 4.83 40.78% | -3.08 163.83% | 1.50 148.59% | -3.50 333.81% | -1.61 54.01% | -1.57 2.27% | -5.07 222.35% | |
sales general and administrative to revenue | 36.01 - | ||||||||||
shareholders equity per share | 0.00 - | -4.79 19,209,212.60% | -7.23 50.81% | -14.07 94.58% | 15.14 207.58% | 7.75 48.80% | 3.23 58.30% | 4.58 41.77% | 0.60 86.82% | 3.87 540.14% | |
stock based compensation to revenue | 16.94 - | 3.14 81.48% | 3.83 22.02% | 8.15 112.90% | 2.86 64.84% | 2.53 11.68% | |||||
tangible asset value | 9 - | -1.56M 17,365,666.67% | -3.44M 120.36% | -7.49M 117.48% | 9.85M 231.56% | 4.01M 59.30% | 2.58M 35.55% | 10.16M 293.04% | 8.01M 21.15% | 2.33M 70.96% | |
tangible book value per share | 0.00 - | -4.79 19,209,212.60% | -7.23 50.81% | -14.07 94.58% | 15.14 207.58% | 5.33 64.80% | 2.16 59.49% | 4.14 91.62% | 0.59 85.65% | 3.83 544.67% | |
working capital | 9 - | 18.54K 205,933.33% | -3.44M 18,673.05% | -7.68M 123.03% | 8.99M 217.02% | 3.44M 61.74% | 2.26M 34.25% | 9.94M 339.67% | 14.71M 47.96% | 5.42M 63.16% |
All numbers in (except ratios and percentages)